Genotype-guided comparison of VEN/HMA versus intensive chemotherapy in newly diagnosed intermediate-risk AML: a multicenter real-world study.

ABSTRACT:

SUBMITTER: Chen X 

PROVIDER: S-EPMC12501211 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature